Clinical Trial Update: Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART) [Phase 4]

View source ↗

Summary

This Phase 4 trial (ReSTART) tested rapid reinitiation of Symtuza in HIV-1-infected, treatment-experienced patients off therapy. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: The Crofoot Research Center, Inc. | Conditions: HIV-1-infection | Phase 4 | Status: COMPLETED